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Polymorphonuclear neutrophils, besides their involvement in primary defense against infec-
tions – mainly through phagocytosis, generation of toxic molecules, release of enzymes,
and formation of extracellular traps – are also becoming increasingly important for their con-
tribution to the fine regulation in development of inflammatory and immune responses.
These latter functions of neutrophils occur, in part, via their de novo production and release
of a large variety of cytokines, including chemotactic cytokines (chemokines). Accordingly,
the improvement in technologies for molecular and functional cell analysis, along with
concomitant advances in cell purification techniques, have allowed the identification of a
continuously growing list of neutrophil-derived cytokines, as well as the characterization of
their biological implications in vitro and/or in vivo.This short review summarizes crucial con-
cepts regarding the modalities of expression, release, and regulation of neutrophil-derived
cytokines. It also highlights examples illustrating the potential implications of neutrophil-
derived cytokines according to recent observations made in humans and/or in experimental
animal models.
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INTRODUCTION
The immune system is well suited to a quick and specific response
against foreign invaders, its ultimate objective being to protect an
organism from injury and disease. Cytokines represent an inte-
gral component of the signaling networks among various cells,
being, for instance, essential for the development and regulation
of innate and adaptive immune processes. Cytokines constitute
a large family of small proteins that are produced by immune
and non-immune cells and that act locally among neighboring
cells to direct important biological processes such as inflam-
mation, immunity, repair, and angiogenesis (1). In this context,
the relatively recent acquisition that also activated neutrophils,
among leukocytes, are able to express and release a number of
cytokines (2) has convinced researchers in the field to reconsider
and thus reinvestigate neutrophil biological role not only in the
context of inflammatory processes, but also in other conditions
(3–5). By doing so, it has clearly emerged that, given the large
array of cytokines that may potentially be produced (Figure 1),
Abbreviations: APRIL, a proliferation inducing ligand; BAFF, B-cell activating
factor; BNDF, brain-derived neurotrophic factor; Bv8, bombina variegata pep-
tide 8; HB-EGF, heparin-binding endothelial growth factor, (EGF)-like growth
factor; FGF2, fibroblast growth factor-2; G-CSF, granulocyte colony-stimulating fac-
tor; GM-CSF, granulocyte/macrophage-colony-stimulating factor; HGF, hepatocyte
growth factor; IL1-ra, interleukin 1 receptor antagonist; LIGHT, lymphotoxin-
related inducible ligand that competes for glycoprotein D binding to HVEM on
T cells; M-CSF, macrophage-colony-stimulating factor; MIF, macrophage migra-
tion inhibitory factor; MIP2, macrophage inflammatory protein 2; NGF, nerve
growth factor; NT4, neurotrophin 4; PBEF, pre-B-cell colony enhancing factor;
RANKL, receptor activator of nuclear factor kappa-B (NFκB) ligand; SCF, stem
cell factor; TGFα, transforming growth factor alpha; TGFβ, transforming growth
factor beta; TRAIL, TNF-related apoptosis-inducing ligand; TSLP, thymic stromal
lymphopoietin; VEGF, vascular endothelial growth factor.
neutrophils can be functionally involved either in physiological
processes such as hematopoiesis, angiogenesis, and wound healing
(2, 6), or in pathological processes including inflammatory, infec-
tious, autoimmune, and neoplastic diseases (2, 4, 7, 8). Needless
to say that, based on the afore-mentioned considerations, there is
an increasing interest in clearly identifying and characterizing all
the cytokines that neutrophils may produce, as well as their precise
role in diseases, with the purpose of identifying novel targets for
therapeutic interventions.
CYTOKINE EXPRESSION IN NEUTROPHILS: TOOLS AND
CAVEATS
Our knowledge of the production of cytokines by neutrophils
mostly derives from studies on humans and mice. Human neu-
trophils are usually isolated from the peripheral blood, while
murine neutrophils are traditionally isolated from the bone mar-
row or the peritoneal cavity. Similarly to other cell types, also
in neutrophils the production of cytokines is usually preceded
by an increased accumulation of the related mRNA transcripts,
which can be detected by techniques such as quantitative reverse-
transcription polymerase chain reaction (qPCR), Northern Blot-
ting, ribonuclease protection assay, and in situ hybridization (9).
The fact that, per-cell, neutrophils possess 10–20 times less RNA
than other leukocytes (10), illustrates the need for using rigor-
ous isolation procedures to allow the recovery of highly purified
cell populations. In fact, a mononuclear cell contamination of neu-
trophils equal to only 1% (or even less) can translate into up to 20–
30% RNA contamination (9): the latter, depending on the expres-
sion levels of the cytokine mRNA under study, may obviously
produce false positive results attributed to neutrophils. Nowa-
days, reliable tools guaranteeing the isolation of highly purified
CD66b+/C11b+/CD16− neutrophils (e.g., by immunomagnetic
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FIGURE 1 | Cytokines that neutrophils can potentially express and/or
produce. Expression and/or production of the listed cytokines have been
validated in human (A) and murine (B) neutrophils by gene expression
techniques, immunohistochemistry, enzyme-linked immunoadsorbent assays
(ELISAs), or biological assays. *Refers to studies performed at the mRNA
level only. ? Indicates controversial data.
negative selection) are commercially available (11, 12). Even in
mice, cytokine production by neutrophils should be carefully
reevaluated by utilizing Ly6Ghigh/CD11bhigh positive cells only,
as recently done (13).
It is also important to mention that, at least in vitro and with
few exceptions, neutrophils usually make fewer molecules of a
given cytokine than monocytes/macrophages or lymphocytes do
on a per-cell basis (2, 10). In vivo, however, neutrophils consti-
tute the majority of infiltrating cells in inflamed tissues and often
outnumber mononuclear leukocytes by one to two orders of mag-
nitude. Thus, the fact that neutrophils clearly predominate over
other cell types under various in vivo conditions suggests that,
under those circumstances, the contribution of neutrophil-derived
cytokines can be of foremost importance. In any case, neutrophil-
derived cytokines can be measured in cell-free supernatants or in
cell lysates by using various methods, including enzyme-linked
immunoadsorbent assays, radioimmunoassays, immunoprecipi-
tation after metabolic labeling, bioassays, immunohistochemistry,
intracellular staining by flow cytometry, or confocal microscopy.
In our opinion, the latter two techniques should be used only
to support other methods, due to potential artifacts consequent
to antibody cross-reactivity or elevated neutrophil autofluores-
cence. Another important caveat for in vitro studies regards the
necessity to always use endotoxin-free tissue culture media or
reagents, since neutrophils respond to picomolar concentrations
of lipopolysaccharide (LPS) (2, 10).
The literature demonstrates that neutrophils express and
produce cytokines either constitutively or upon activation by
microenvironmental stimuli (2). A variety of neutrophil recep-
tors, including colony-stimulating factor and cytokine receptors,
G protein coupled-, Fcγ- and complement receptors, or many
pattern recognition receptors (PRR) (germline-encoded recep-
tors recognizing structures in microorganisms and tissue damage
products), have been shown to trigger cytokine production in neu-
trophils (2, 14). Among PRR, human and mice neutrophils are
known to express almost all Toll-like receptors (TLRs), as well as
to respond to their ligands [(15), and references therein]. TLR3
and TLR7 are actually the only TLRs that human neutrophils
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do not express (16–18), unlike murine neutrophils that instead
accumulate significantly high levels of TLR7 mRNA under inflam-
matory conditions (19, 20). Moreover, murine neutrophils do not
basally express TLR3 transcripts (16, 21, 22) even though even-
tual accumulation has never been quantified under inflammatory
condition. Interestingly, in human neutrophils, TLR4 activation
by LPS fails to directly trigger the production of type I INFs and
type I IFN-dependent genes as in other cell types (23, 24), due to
its inability to engage the so called “TIR domain-containing adap-
tor protein inducing interferon β (TRIF)/TRIF-related adaptor
molecule (TRAM)”-dependent pathway (23, 24).
Finally, an increasing number of studies have documented that
TLR-induced cytokine expression by neutrophils can be posi-
tively/negatively influenced by immunomodulating factors such
as IFNγ (25, 26) and IL-10 (27), respectively.
Following stimulation, neutrophils control their cytokine
expression and production patterns by utilizing fine regula-
tory mechanisms acting at the transcriptional and/or post-
transcriptional level (2, 4, 7, 28). Interestingly, recent studies have
demonstrated that also microRNAs may regulate cytokine and
chemokine production in neutrophils. For instance, miR9 was for
the first time demonstrated to inhibit NFKB1/p50 transcripts in
human neutrophils exposed to pro-inflammatory signals, oper-
ating in this manner as a feedback control for NFKB1/p50-
dependent responses (29). More recently, miR-223 has been shown
to negatively control the production of CXCL2, CCL3, and IL-6
by neutrophils, in a mouse model of Mycobacterium tuberculo-
sis infection (30). These latter data have contributed in shedding
light on the hitherto controversial role of neutrophils in tuberculo-
sis (31), as they suggest that miR-223-dependent inhibitory effects
may negatively control leukocyte chemotaxis at late stages of lung
inflammation by means of developmentally accumulated miR-
223 (30). Interestingly, examples of de novo synthesized cytokines
that neutrophils store in significant amounts within intracellu-
lar pools also exist, and include B-cell activating factor (BAFF),
TNF-related apoptosis-inducing ligand (TRAIL), CXCL8, CCL20,
and interleukin (IL) 1 receptor antagonist (IL1-ra) (32, 33). How-
ever, very little is known on the precise intracellular localization
and trafficking of these various cytokines and chemokines. Thus,
much more work is needed to understand if, and how, the various
neutrophil granules or other intracellular organelles contribute to
cytokine metabolism and release (34).
CYTOKINE PRODUCTION BY NEUTROPHILS: FACTS
Figure 1 displays the cytokines that, to date, have been
shown to be expressed or produced by, respectively, human
(panel A) and murine (panel B) neutrophils, either con-
stitutively or upon stimulation. It is evident that neu-
trophils express/produce cytokines belonging to various families,
mostly including pro-inflammatory/anti-inflammatory cytokines,
chemokines, immunoregulatory cytokines, tumor necrosis factor
(TNF) superfamily members, and angiogenic/fibrogenic factors.
At first sight, an analysis of the figure immediately suggests that
the ability of neutrophils to produce such a variety of cytokines
enables them to significantly influence not only the multiple
aspects of the inflammatory and immune responses, but also
antiviral defense, hematopoiesis, angiogenesis, and fibrogenesis.
Importantly, numerous in vivo observations have confirmed and
reproduced the in vitro findings, as well as often clarifying their
biological meanings and implications (2). It can also be noticed
that, in spite of a substantial conservation between the human and
murine genomes (35), some differences in cytokine production
exist between the two species (Figure 1), thus warning toward a sic
et simpliciter extrapolation of data from experimental systems in
animals to humans, or vice versa. In the case of IL-10, for instance,
basal differences in the chromatin status of the IL-10 locus, rather
than a different responsiveness to activating signals, have been
shown to account for the differential ability of human and murine
neutrophils to switch on transcription of the IL-10 gene (36).
In the following paragraphs, some up-to-date findings
illustrating potential biological roles that neutrophil-derived
chemokines, pro-inflammatory/immunoregulatory cytokines,
and TNF-superfamily members might have, under pathophysi-
ological contexts, are briefly mentioned. For an extensive descrip-
tion on the role of neutrophil-derived cytokines in cancer and in
angiogenesis, the reader may refer to our recent reviews (6, 8).
CHEMOKINES
Chemokines, amongst the cytokines produced by neutrophils,
are of particular relevance because of their singular ability to
selectively recruit discrete cell populations into sites of injury
and thereby effectively regulate leukocyte trafficking (37). In
addition, chemokines play fundamental roles in coordinating
immune system responses, in regulating B- and T-cell devel-
opment and in modulating angiogenesis (38). As displayed in
Figure 1, both human and murine neutrophils may poten-
tially produce several chemokines upon activation, including
IL-8/CXCL8, GROα/CXCL1, MIG/CXCL9, IP-10/CXCL10, and I-
TAC/CXCL11, monocyte chemotactic protein-1 (MCP-1/CCL2),
macrophage inflammatory protein-1α (MIP-1α/CCL3) and MIP-
1β/CCL4 (37). Because the chemokines produced by neutrophils
are primarily chemotactic for neutrophils, monocytes, dendritic
cells (DCs), natural killer (NK) cells, and T-helper type 1 (Th1)
and type 17 (Th17) cells, a potential role for neutrophils in
amplifying their own arrival (39), as well as in orchestrating
the sequential recruitment to, and activation of, distinct leuko-
cyte types in the inflamed tissue, is plausible (37, 40). And in
fact, in in vitro experiments, it has been demonstrated that: (i)
human neutrophils activated by neutrophil-activating protein A
from Borrelia burgdorferi recruit IFNγ- and IL-17-producing T
lymphocytes via CCL2, CCL20, and CXCL10 release (41); (ii) LPS-
activated neutrophils induce chemotaxis of immature and mature
DCs, as well as adhesion of CCR6- and CCR7-expressing T cells
via CCL19 and CCL20 (42); and (iii) IFNγ plus LPS-activated
neutrophils induce chemotaxis of Th17 cells through CCL2 and
CCL20 (11). Moreover, in different mouse models it has been
proved that: (i) DCs are recruited to the Leishmania inocula-
tion site by neutrophil-derived CCL3 (43); (ii) immature DCs are
strongly attracted by neutrophil-derived CCL3, CCL4, CCL5, and
CCL20 triggered by Toxoplasma gondii (44); and (iii) macrophage
influx to granulomas is dependent on CCL3 and CCL4 released
by activated neutrophils (45). More recently, CCL17, a chemokine
that binds to CCR4, a chemokine receptor expressed in T-helper
type 2 (Th2) cells and in regulatory T cells (Tregs) (46), has been
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added to the list of neutrophil-derived chemokines (47, 48). Con-
sistently, tumor-associated neutrophils (TANs) have been shown
to chemoattractants Tregs in a mouse model of cancer, mainly
via CCL17 (49). Because neutrophil depletion, in this model,
was shown to reduce Tregs recruitment and, consequently, tumor
growth, data provide, for the first time, a clear link between TANs
and Tregs, acting together to impair antitumor immunity (49).
PRO-INFLAMMATORY AND IMMUNOREGULATORY CYTOKINES
As shown in Figure 1, neutrophils may become a significant
source of pro-inflammatory and/or immunoregulatory cytokines.
Among these cytokines, recent research has focused on neutrophil-
derived IL-17 and IFNγ, as well as on their eventual role in inflam-
matory diseases and/or in protection against infections. However,
since the data on the effective capacity of human neutrophils to
express/produce IL-17 (11, 50) or IFNγ (51, 52) are still contro-
versial in literature, we can only report on studies carried out
in mice.
For instance, IL-23- and, indirectly, IL-12-, activated Gr-1+-
neutrophils, but not Th17 cells, have been found to be the pre-
dominant source of IL-17A in a mouse model of kidney ischemia-
reperfusion injury (IRI) (53). Such neutrophil-derived IL-17 has
been then shown to regulate natural killer T cells (NKT) activation,
IFNγ production, neutrophil infiltration, ultimately inflamma-
tion, and tissue injury (53), thus establishing its requirement
for kidney injury following IRI. In another, more recent study,
researchers have identified a murine population of bone mar-
row neutrophils that constitutively express the transcription factor
RORγt, and that rapidly produce and respond to IL-17A in a IL-
23 plus IL-6-dependent manner (54). Autocrine activity of IL-17A
on such neutrophil subset has been shown not only to induce the
production of reactive oxygen species (ROS), but also to increase
neutrophil-mediated fungal killing in vitro and, importantly, also
in an in vivo model of Aspergillus fumigatus-induced keratitis (55).
In a similar fashion, IL-17A produced by Ly6G+-neutrophils, but
not by NKT or γδT cells, was found to be important in pro-
viding protection against early pneumonic plague infection in
mice (56). In this model, however, neutrophil-derived IL-17A did
not significantly change neutrophil bactericidal activities, but was
instead crucial for the IFNγ-mediated programming of M1 pro-
inflammatory macrophages after Yersinia pestis challenge (56).
A number of in vivo experiments have reported that, in response
to a variety of pathogens, including Nocardia asteroides (57), Lis-
teria monocytogenes (58), and Plasmodium berghei (59), murine
neutrophils secrete IFNγ, a crucial orchestrator for host defense
against intracellular pathogen. Neutrophils have been found to
be an important source of IFNγ also upon Toxoplasma gondii
infection, in a model of genetically modified mice lacking all
lymphoid cells due to deficiencies in Recombination Activating
Gene 2 (RAG2) and IL-2Rγc genes (60). In these mice, although
insufficient for complete host protection, neutrophil-derived IFNγ
was found to be TLR11-independent and to significantly reduce
pathogen load therefore extending mice survival (60). Moreover,
other studies have shown that migrated neutrophils are responsi-
ble for the early production of IFNγ during pneumonia infections,
in turn regulating bacterial clearance in mice (61). Interestingly,
such IFNγ production does not require either IL-12, or CD11/18
complex, CD44, TLR2, TLR4, TRIF, and Nrf2, while it is nearly
abolished in Nox2 deficient mice (62). Altogether, data not only
underline the complexity of the neutrophil responses during pneu-
monia, but also highlight how tightly regulated is the process of
IFNγ induction in neutrophils, as it likely involves interactions
between multiple signaling pathways.
TNF-SUPERFAMILY MEMBERS
Human and murine neutrophils also express and produce many
TNF-superfamily members (Figure 1A,B), although at variable
levels (2). For example, human neutrophils synthesize – at least
in vitro – very low amounts of TNFα (in the order of picogram
per milliliter per million cells) in response to TLR agonists (2),
which nonetheless exert potent autocrine effects in amplifying
neutrophil-derived cytokines and chemokines [(63) and other
unpublished observations from our group]. In vivo, neutrophil-
derived TNFα has been recently described to either instruct skin
Langerhans cells to prime antiviral immune responses (64), or to
stimulate melanoma cells to migrate towards endothelial cells and
metastasize to the lungs, in a mouse model of primary cutaneous
melanoma undergoing repetitive ultraviolet (UV) exposure (65).
Moreover, through application of confocal intravital microscopy
to the mouse cremaster muscle, it has been very recently shown
that chemoattractans-responding neutrophils release TNFα when
in close proximity of endothelial cell junctions. Further, in TNF
receptor (TNFR) (−/−) mice, neutrophils accumulated normally
in response to chemoattractants administered to the cremaster
muscle or dorsal skin, whereas neutrophil-dependent plasma pro-
tein leakage was abolished, suggesting that neutrophil-derived
TNFα mediates microvascular leakage (66).
On the other hand, neutrophils have turned-out as a major
source of both BAFF (67) and a proliferation inducing lig-
and (APRIL) (68), two TNF members that are critical for B-
cell maturation, function, and survival. Accordingly, BAFF and
APRIL (other than IL-21 and, possibly, CD40L) have proven to
be fundamental mediators of the functions of a recently iden-
tified neutrophil subset in human spleen – the so called “B-
helper” neutrophil subset – precisely for their ability to stimu-
late immunoglobulin diversification and production by splenic
marginal zone B-cells (69). An involvement of BAFF-producing
splenic neutrophils in the pathogenesis of murine lupus has been
also demonstrated in a recent study, suggesting that neutrophils
help to shape CD4+ T cell responses via BAFF, which in turn
contributes to the production of pathogenic autoantibodies (70).
Finally, another TNF-superfamily member that both human
and murine activated neutrophils can produce and release is
TRAIL, a trans-membrane/soluble molecule involved in tumor
cell killing and autoimmunity (33). In humans, neutrophil-
derived TRAIL has been classically detected ex vivo in the con-
text of intravesical BCG infusion and systemic IFNα adminis-
tration to treat, respectively, bladder cancer and chronic myeloid
leukemia (71, 72). Since previous in vitro data had shown an effec-
tive TRAIL-mediated cytotoxicity of neutrophils towards leukemic
cells (73, 74), it is conceivable to hypothesize further studies aimed
at harnessing neutrophils against tumors, possibly via TRAIL
induction. Nonetheless, our knowledge on the TRAIL production
by neutrophils has been more recently extended to the mouse
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system, as neutrophil-derived TRAIL has been shown to exert
antiviral activities in a model of cytomegalovirus infection (75),
as well as to mediate early bacterial killing in a model of pneumo-
coccal pneumonia (76). Based on the afore-mentioned and other
(2, 8, 42, 43) observations, it appears that TNF-superfamily mem-
bers may contribute to a large extent to unexpected functions that
neutrophils may exert.
CONCLUDING REMARKS
During the past decades, novel functions in homeostasis and
pathology have emerged for neutrophils, mainly for their ability
to represent a source for a variety of cytokines. It is plausible that
with the development of very efficient cell isolation techniques
and the increased availability of neutrophils purified from vari-
ous compartments, such as spleen, peritoneal exudates, lungs, oral
cavity, skin, bone marrow, cord blood, and placenta, our knowl-
edge of the repertoire of cytokines produced by human and mouse
neutrophils will expand.
Apart from what has been briefly summarized in this review, a
number of issues remain to be better explored and/or clarified in
this research area.
For instance, we need to elucidate all the stimuli that are
able to induce cytokine synthesis in neutrophils. Such stud-
ies would be particularly helpful in understanding the patho-
genesis of diseases in which neutrophils represent (or are pre-
sumed to be) the first cell type encountering, and interacting
with, the etiologic agent. In fact, we know that the interaction
of neutrophils with a given agonist produces a characteristic,
stimulus-specific response (2). The recent findings that human
neutrophils possess intracellular sensor systems that allow the
recognition of foreign and potentially dangerous RNA and DNA,
as well as the inflammasomes (17, 77–80), demonstrates that
neutrophils, via cytokine/chemokine release, are in the position
to act at the front-line of immunity not only toward extracel-
lular, but also toward intracellular microorganisms, including
viruses. Another aspect that needs to be more systematically
dissected concerns the identification of the molecular mecha-
nisms controlling cytokine expression in neutrophils. Such stud-
ies may lead to the identification of novel, maybe neutrophil-
specific, transcription factors, or of neutrophil-specific chromatin
organization programs (36). Finally, more information on the
in vivo role of neutrophil-derived cytokines should be acquired
in humans, since it mostly derives from experimental animal
models. By doing so, it is tempting to predict that unantici-
pated functions of neutrophils can be discovered. Future chal-
lenges for scientists in the field will be to translate all these
new insights into efficacious neutrophil-targeted therapies for
the treatment of inflammatory conditions without compromising
immunity.
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